Mahdi Yahyazadeh Balalami | Biological Sciences | Young Scientist Award

Assist. Prof. Dr. Mahdi Yahyazadeh Balalami | Biological Sciences | Young Scientist Award

Researcher from Research Institute of Forests and Rangelands, Iran

Mahdi Yahyazadeh Balalami is a dedicated researcher specializing in plant secondary metabolites, particularly medicinal alkaloids. With a robust academic foundation and over a decade of research experience, he has established himself in the fields of plant biology, phytochemistry, and analytical techniques. He is currently an Assistant Professor at the Medicinal Plant Research Division, Research Institute of Forests and Rangelands in Tehran, Iran, where he focuses full-time on research. Mahdi has contributed extensively to understanding the biosynthesis and purification of plant alkaloids, including significant work on Papaver somniferum and Catharanthus roseus. His scientific journey is marked by international collaborations with prestigious institutions such as the Technische Universität Braunschweig in Germany and Kyoto University in Japan. His hands-on experience in molecular biology, chromatography, and gene expression analysis demonstrates his versatility and commitment to scientific innovation. He has also served as a scientific consultant for industry, bridging the gap between academic research and practical applications. Mahdi’s scholarly achievements are reflected in his awards, publications, and the application of his work in pharmaceutical development. His career trajectory underscores a strong dedication to advancing plant-based therapeutic research and applying it in both academic and industrial contexts.

Professional Profile

Education

Mahdi Yahyazadeh Balalami holds an impressive academic background across various institutions and countries. He earned his Ph.D. in Plant Biology from Technische Universität Braunschweig in Germany between August 2013 and July 2017. His dissertation, supervised by Professor Dirk Selmar, focused on the impact of abiotic stress on alkaloid biosynthesis, a critical topic for both plant biology and pharmaceutical applications. His doctoral performance was graded as “Very Good.” Prior to that, Mahdi completed his Master of Science in Agricultural Engineering with a specialization in Horticulture Science from Tarbiat Modares University, Tehran, Iran, in January 2007. His MSc thesis addressed the effects of essential oils on extending the shelf life of orange fruits, demonstrating his early interest in plant-derived bioactive compounds. He earned a Bachelor’s degree in Agricultural Engineering – Plant Products from Islamic Azad University, Chalous, Iran, in 2000 with a GPA of 17.18/20. Mahdi also holds an Associate Degree in Orchard Products Technology from Tonekabon Agricultural Higher Education Institute. His academic progression reflects a consistent focus on plant sciences, particularly those with practical implications for health and agriculture. Each stage of his education laid a foundation for his future research on medicinal plants and their chemical constituents.

Professional Experience

Dr. Mahdi Yahyazadeh Balalami’s professional experience spans academic research, industry consultancy, and international collaborations. Since January 2020, he has served as an Assistant Professor at the Medicinal Plant Research Division of the Research Institute of Forests and Rangelands in Tehran, Iran, dedicating 100% of his time to research. Simultaneously, since May 2019, he has acted as a scientific consultant at Temad Pharmaceutical Company, focusing on improving alkaloid extraction methods from Papaver species and developing HPLC analysis protocols. Mahdi is also affiliated as a researcher with the Institute for Plant Biology at Technische Universität Braunschweig, Germany, where he collaborates on natural product transfer studies. His prior roles include multiple internships and assistantships in Germany and Japan, notably at Kyoto University and various departments within TU Braunschweig. These experiences involved gene cloning, heterologous expression in yeast, alkaloid purification, and transcriptome analysis. His hands-on experience with chromatography systems, bioinformatics tools, and laboratory instrumentation has made him a well-rounded researcher. Mahdi’s career reflects a balance between theoretical expertise and experimental application, enriched by cross-cultural academic exposure and industrial relevance. His long-standing commitment to medicinal plant research continues to yield valuable insights into phytochemical biosynthesis and plant-based therapeutics.

Research Interests

Mahdi Yahyazadeh Balalami’s research interests lie at the intersection of plant biology, phytochemistry, molecular genetics, and pharmacognosy. His primary focus is on the biosynthesis, extraction, and analysis of plant-derived alkaloids with therapeutic potential. His research explores the biochemical and genetic pathways of alkaloid production in medicinal plants such as Chelidonium majus, Catharanthus roseus, and Papaver somniferum. He is particularly interested in how abiotic stress influences secondary metabolite biosynthesis, a subject he explored deeply during his Ph.D. studies. Mahdi’s academic work is complemented by applied research on improving extraction techniques and developing advanced HPLC methods for the pharmaceutical industry. He has also contributed to projects involving horizontal natural product transfer, which investigates how bioactive compounds can move between organisms or across species boundaries—a novel area with implications for synthetic biology and drug discovery. Furthermore, his collaborations with institutions in Germany and Japan have broadened his expertise in gene cloning, yeast expression systems, and countercurrent chromatography. Mahdi’s research ultimately aims to enhance the efficiency, sustainability, and biological relevance of plant-based drug production through a better understanding of plant metabolism and bioengineering.

Research Skills

Dr. Mahdi Yahyazadeh Balalami possesses a comprehensive and highly specialized set of research skills in plant molecular biology and phytochemistry. He has extensive experience in cloning P450 genes and expressing them in yeast systems, demonstrating his strong molecular biology foundation. His work includes transcriptomic analysis using qRT-PCR to study gene expression in alkaloid biosynthesis pathways, particularly involving enzymes like stylopine synthase. Mahdi is proficient in a range of analytical techniques such as HPLC-DAD, LC-MS, LC-MS/MS, GC-MS, NMR, and X-ray crystallography, which he has used for the purification and structural elucidation of plant alkaloids. His hands-on experience with Counter Current Chromatography (CCC) and preparative chromatography allows him to isolate bioactive compounds with high precision. He is also skilled in handling plant growth under controlled environmental conditions, essential for studying secondary metabolite production. His familiarity with bioinformatics tools such as MEGA7, BioEdit, SAS, SPSS, Maestro, Chimera, and Autodock Vina enables him to analyze sequences and model molecular interactions. This integration of wet-lab and computational expertise allows Mahdi to conduct interdisciplinary research that bridges plant science, pharmacology, and biotechnology. His methodological rigor and technical versatility make him a valuable contributor to medicinal plant research.

Awards and Honors

Mahdi Yahyazadeh Balalami has received several notable awards and recognitions throughout his academic and research career. During his Ph.D. studies, he was awarded a 48-month scholarship by the Iranian Ministry of Science, Research and Technology, supporting his education at Technische Universität Braunschweig in Germany from 2013 to 2017. This competitive scholarship reflects both his academic excellence and the national confidence in his research potential. Earlier, in 2004, Mahdi ranked 12th among more than 1500 candidates in Iran’s nationwide M.Sc. entrance examination, securing a place at the prestigious Tarbiat Modares University. In 2009, he was honored by the Iranian Nano Committee for his contribution to nano-related research, underlining his early engagement in innovative scientific domains. These honors highlight not only his academic diligence but also his consistent trajectory of achievement across different levels of education and research. Recognition from both national bodies and research institutions reinforces the impact and quality of his scientific contributions. These awards reflect a strong commitment to advancing plant-based biotechnology, further cementing his position as a researcher capable of delivering both foundational knowledge and practical applications in the field of medicinal plant science.

Conclusion

In conclusion, Dr. Mahdi Yahyazadeh Balalami exemplifies the qualities of an outstanding researcher in the field of medicinal plant science. His career is marked by a clear focus on plant-derived bioactive compounds, with notable specialization in alkaloid biosynthesis, extraction, and analysis. His work bridges fundamental plant biology and practical pharmaceutical applications, and he has demonstrated strong leadership in both academic and industrial research settings. Mahdi’s extensive international experience, especially in Germany and Japan, showcases his collaborative spirit and adaptability across research cultures. He is equipped with a rare combination of skills in molecular biology, phytochemistry, and analytical instrumentation, supported by his use of advanced software tools. His educational achievements, research excellence, and multiple recognitions further affirm his dedication and competence. While his research output could benefit from broader publication visibility and expanded interdisciplinary collaborations, his foundation is exceptionally strong. Mahdi is a well-qualified candidate for the Best Researcher Award, and his continued work holds promise for significant advancements in natural product research and pharmaceutical development. His career reflects a persistent drive to contribute meaningful scientific knowledge and innovation in the realm of medicinal plants and plant-based therapeutics.

Publications Top Notes

  1. High variations of the thebaine concentrations in Iranian poppy (Papaver bracteatum Lindl.) from various regions in Iran
    Authors: Mahdi Yahyazadeh, Mahshid Rahimifard, Najmeh Hadi, Zahra Shirazi, Samaneh Asadi-sanam, Razieh Azimi, Yousef Ajani, Maryam Makizadeh, Aiuob Moradi, Mahmood Bidarlord, et al.
    Year: 2024

  2. A Major Loss of Phenyl Ethyl Alcohol by the Distillation Procedure of Rosa damascene Mill
    Authors: Kamkar Jaimand, Mohammad Bagher Rezaee, Razieh Azimi, Someyeh Fekry, Mahdi Yahyazadeh, Shahrokh Karimi, Firoozeh Hatami
    Year: 2023

  3. Chemical composition of essential oil in Anthemis lorestanica from Isfahan province in Iran
    Authors: K. Jaimand, S. Davazdahemami, B. Bahreininejad, L. Safaii, F. Sefidkon, M. B. Rezaei, R. Azimi, M. Yahyazadeh, S. Karimi, F. Hatamy, et al.
    Year: 2023

  4. Effect of Geographical Location on Yield and Chemical Composition of Teucrium orientale L. Essential Oils Collected from Eleven Different Localities in Iran
    Authors: Mahshid Rahimifard, Fatemeh Sefidkon, Razieh Azimi, Somayeh Fekri Qomi, Maryam Makkizadeh Tafti, Mahmoud Naderi, Mahdi Yahyazadeh, Parvin Salehi Shanjani
    Year: 2023

  5. Genome-wide identification and expression profile analysis of metal tolerance protein gene family in Eucalyptus grandis under metal stresses
    Authors: Zahra Shirazi, Fatemeh Khakdan, Fariba Rafiei, Mahdi Yahyazadeh Balalami, Mojtaba Ranjbar
    Year: 2023

  6. Impact of Aridity on Specialized Metabolism: Concentration of Natural Products in Plants
    Authors: Mahdi Yahyazadeh, Sara Abouzeid, Laura Lewerenz, Tahani Hijazin, Dirk Selmar
    Year: 2023

  7. Impact of Aridity on Specialized Metabolism: Concentration of Natural Products in Plants
    Book Chapter in: Medicinal Plants: Their Response to Abiotic Stress
    Authors: M. Yahyazadeh, S. Abouzeid, L. Lewerenz, T. Hijazin, D. Selmar
    Year: 2023

  8. Bio-evaluation of Untapped Alkaloids from Vinca minor Enriched by Methyl-jasmonate-induced Stress: an Integrated Approach
    Authors: F. F. El-Senduny, A. A. Elgazar, H. A. Alwasify, A. Abed, M. Foda, S. Abouzeid, L. Lewerenz, D. Selmar, F. Badria
    Year: 2022

  9. Biochemistry and Molecular Basis of Intracellular Flavonoid Transport in Plants
    Authors: B. Pucker, D. Selmar
    Year: 2022

  10. Favorable Impacts of Drought Stress on the Quality of Medicinal Plants: Improvement of Composition and Content of Their Natural Products
    Authors: S. Abouzeid, L. Lewerenz, M. Yahyazadeh, A. Radwan, T. Hijazin, M. Kleinwächter, D. Selmar
    Year: 2022

  11. Horizontal Natural Product Transfer: A Phenomenon Which Is Responsible for the Widespread Alkaloidal Contaminations of Herbal Products
    Authors: T. Hijazin, L. Lewerenz, M. Yahyazadeh, D. Selmar
    Year: 2022

Jiangang Duan | Neuroscience | Best Researcher Award

Prof. Jiangang Duan | Neuroscience | Best Researcher Award

Chief Physician at Xuanwu Hospital, Capital Medical University, China

Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

  1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
    Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
    Journal: International Journal of Stroke
    Year: 2024
    Volume & Pages: 19(6), pp. 635–644
    Citations: 2
  2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
    Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
    Journal: Brain and Behavior
    Year: 2024
    Volume & Pages: 14(4), e3353
  3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
    Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
    Journal: Heliyon
    Year: 2024
    Volume & Pages: 10(4), e25916
  4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
    Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
    Journal: Current Neurovascular Research
    Year: 2024
    Volume & Pages: 21(1), pp. 6–14
  5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
    Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
    Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
    Year: 2024
    Volume & Pages: 24(3), pp. 193–198
  6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
    Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
    Journal: Journal of Clinical Pharmacy and Therapeutics
    Year: 2024
    Volume & Pages: Article ID: 1171260
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
    Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
    Journal: European Stroke Journal
    Year: 2023
    Volume & Pages: 8(4), pp. 1001–1010
    Citations: 1
  8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
    Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
    Journal: Thrombosis Journal
    Year: 2023
    Volume & Pages: 21(1), Article 78
    Citations: 1
  9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
    Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
    Journal: Ultrasound in Medicine and Biology
    Year: 2023
    Volume & Pages: 49(10), pp. 2221–2226
  10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3